REGD. NO. D. L-33004/99
The Gazette of India
EXTRAORDINARY
PART II—Section 3—Sub-section (i)
PUBLISHED BY AUTHORITY
No. 46]
NEW DELHI, THURSDAY, FEBRUARY 1, 2001/MAGHA 12,1922
(1)
122 GI/ 2001
•
AR
II—, ... .
3
4
THE GAZETTE OF INDIA : EXTRAORDINARY
[P \KT U—SKC. Mi)]
5
6
THE GAZETTE OF INDIA : EXTRAORDINARY
[PART II—SEC. 3(i)l
7
5 _
GA
OF
A:
A
MARY
[PART H—SEC. 3(i)1
A :
A
slARY
[PART II—SEC. 3(i)1
n
\2
THE GAZETTE OF INDIA : EXTRAORDINARY
[PART II—SEC. 3(i)]
13
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Indian Systems of Medicine and Homoeopathy)
NOTIFICATION
New Delhi, the 31st January. 2001
G. s. R. 53(E).— T h e following draft of certain rules further to amend the Drugs and Cosmetics
Rules, 1945, which the Central Government after consultation with the Ayurvedic, Siddha and
Unani Drugs Technical Advisory Board proposes to make, in exercise of the powers conferred by
clause(a) of sub-section(l) of section 33-N read with sub-Section(l), clauses(d) and (f) of sub-
Section(2) of Section 6 of the Drugs and Cosmetics Act, 1940 (23 of 1940), is hereby published as
required by the said section for the information of all persons likely to be affected thereby and
notice is hereby given that the said draft rules will be taken into consideration after the expiry of a
period of forty-five days from the date on which copies of the Official Gazette in which this
notification is published, are made available to the public;
Objections or suggestions, if any, may be addressed to the Secretary, Department of Indian
System of Medicine and Homoeopathy, Ministry of Health and Family Welfare, Indian Red Cross
Society Building, New Delhi - 110001;
Any objection or suggestion, which may be received from any person with respect to the said
draft rules within the period specified
above will be taken into consideration by the Central
Government.
DRAFT RULES
1.
(i). These rules may be called the Drugs and Cosmetics (
Amendment) Rules, 2001
(ii) They shall come into force on the date of final publication in the Official Gazette;
2.
In the Drugs and Cosmetics Rules, 1945, -
(a), after Part XVI, the following shall be inserted, namely-
U
THE GAZETTE OF INDIA : EXTRAORDINARY
[PART II—SEP 3(i)l
FART XVI (A)
APPROVAL OF LABORATORIES FOR CARRYING OUT TESTS OR
ANALYSIS OF AYURVEDIC SIDDHA OR UNANI, DRUGS AND RAW
-MATERIALS USED IN THEIR MANUFACTURE ON jHEHALF OF LICENSEES
FOR MANUFACTURE AND SALE OF AYURVEDIC SIDDHA OR UNANI
DRUGS.
160- A.- Application for grant of approval for testing Ayurvedic, Siddha and Unani
drugs - Application for grant or renewal of approval for carrying out tests or analysis
for identity, purity, quality and strength of Ayurvedic, Siddha or Unani drugs or the raw
materials used in the manufacture thereof on behalf of licensees for manufacture for sale
of Ayurvedic, Siddha or Unani drugs, shall be made in Form 40 to the licensing authority
appointed by the State Government for the purposes in Part XVI, XVII or XVIII of these
rules, as the case may be and referred to as the "approving authority" under this Part and
shall be accompanied by an inspection fee of Rupees six thousand
in respect of
Ayurvedic, Siddha or Unani drugs specified in First Schedule to the Act:
Provided that the applicant shall furnish to the approving authority such additional
information as may be required by him in connection with the application in Form 40:
Provided further that if the application for renewal of approval is made within six
months of such expiry, the inspection fee payable shall be rupees six thousand plus an
additional inspection fee at the rate of rupees one thousand per month in the case of
testing or analysis of Ayurvedic, Siddha or Unani drugs specified in First Schedule to the
Act.
Explanation.- For the purpose of this Part, the words "Ayurvedic, Siddha and Unani
drugs" shall also mean and include the raw materials used in the manufacture of
Ayurveda, Siddha, or Unani drugs, as the case may be.
15
160 -B.- Form in which approval to be granted for carrying out tests on
Ayurvedic, Siddha or Unani drugs on behalf of licensees for manufacture of
Ayurvedic, Siddha or Unani drugs and conditions for grant or renewal of such
approval. -(1) Approval for carrying out such tests or analysis of identity, purity, quality
and strength of Ayurvedic, Siddha and Unani drugs as may be required under the
provisions of these rules, on behalf of licensee for manufacture of
Ayurvedic, Siddha
and Unani drugs shall be granted in Form 41.
(2)
Before approval in Form 41 is granted or renewed, the following conditions shall
be complied with by the applicant namely:-
(i)
The premises where the tests or analysis are carried out shall be well lighted and
properly ventilated except where the nature of tests of any Ayurvedic, Siddha or Unani
drug warrants otherwise. Wherever necessary, the premises shall be air-conditioned so as
to maintain the accuracy and functioning of laboratory instruments or to enable the
performance of special tests such as sterility tests and microbiological tests
(ii) (a) The applicant shall provide adequate space having regard to the nature and
number of samples of drugs proposed to be tested:
Provided that the approving authority shall determine from time to time whether the
space provided continues to be adequate.
(b)
The applicant shall provide a list of persons who are or may be employed with
them as experts, who shall posses at least a degree from a recognized University or
equivalent
in Chemistry, Botany, Degree in Ayurved-Siddha or Unani/ Bachelor in
Pharmacy and having experience as such for at least 2 years for carrying out tests or
analysis as per the Ayurvedic, Siddha or Unani pharmacopoeias or wherever tests are
available for identity, purity, quality and strength of Ayurvedic, Siddha, or Unani drugs.
)6
THE GAZETTE OF INDIA: EXTRAORDINARY
|PAKT II—SEC. 3(i)1
( c )
The applicant shall provide equipments essential for carrying out
tests or analysis for identity, purity and strength of Ayurvedic, Siddha, or Unani drugs.
(3)
The applicant shall provide and maintain suitable equipment having regard to the
nature and number of samples of Ayurvedic, Siddha or Unani drugs intended to be tested
or analysed which shall be adequate in the opinion of the approving authority.
(4)
The testing or analysis of Ayurvedic, Siddha and Unani drugs, as the case may be,
for identity purity quality and strength shall be carried out under the active direction of
one of the experts referred to 2(b) above who shall be the person in charge of testing and
be held responsible for the reports of test or analysis issued by the applicant.
(5)
The testing or analysis of Ayurvedic, Siddha or Unani drugs, as the case may be,
for identity, purity, quality and strength shall be carried out by persons whose
qualifications and experience of testing are adequate (not below the degree qualification)
as mentioned in 2(b) in the opinion of the approving authority.
(6)
The applicant shall provide books of standard recognised under the provisions of
the Act and the rules made thereunder and such books of reference as may be required in
connection with the testing or analysis of the products for the testing or analysis of which
approval is applied for.
(7)
The applicant shall provide list of standard Ayurveda, Siddha or Unani drugs
recognised under the provisions of the Act and rules made thereunder and such reference
samples kept in the laboratory may be required in connection with the testing or analysis
of the products of which approval is applied for.
160 - C- Duration of approval-An approval granted in Form 41 or renewed in Form 42
unless sooner suspended or withdrawn, shall be valid for a period of three years from
the date on which its is granted or renewed:
17
Provided that if an application for the renewal of an approval in Form 40 is made
' before its expiry or if the application is made within six months of its expiry after the
payment of the additional inspection fee, the approval shall continue to be in force until
orders to the contrary are passed on the application and the approval shall be deemed to
have expired if the application for its renewal is not made within six months of its expiry
160 -D.- Conditions of approval - An approval in Form 41 shall be subject to the
following general condition namely:-
(a)
The laboratory granted approval under this Part (hereinafter referred to as the
approved laboratory) shall provide and maintain adequate staff and adequate premises
and equipment as specified in rule 160 (B).
(b)
The approved laboratory shall provide proper facilities for storage so as to
, preserve the properties of the samples to be tested by it.
(c)
The approved laboratory shall maintain records of tests for identity, purity, quality
and strength carried out on all samples of Ayurvedic, Siddha or Unani drugs and the
results thereof together with the protocols of tests showing the readings and calculation in
such form as to be available for inspection and such records shall be retained in the case
of substances for which an expiry date is assigned for a period of two years from the
expiry of such date and in the case of other substances for a period of six years.
(d)
The approved institution shall allow the Inspector appointed under this Act to
enter with or without prior notice the premises where the testing is carried out and to
inspect the premises and the equipment used for test and the testing procedures
employed. The laboratory shall allow the Inspectors to inspect the registers and records
maintained under these rules and shall supply to such Inspectors such information as they
may require for the purpose of ascertaining whether the provisions of the Act and rules
made thereunder have been observed.
322O7j/.M>.B,__3
18
THE GAZETTE OF INDIA EXTRAORDINARY
|PART II—SEC. 3(i)1
(e)
The approved laboratory shall from time to time report to the approving authority
any changes in the person-in-charge of testing of Ayurvedic, Siddha or Unani drugs or
the expert staff responsible for testing, as the case may be, and any material alterations in
the premises or changes in the equipment used for the purposes of testing which have
been made since the date of last inspection made on behalf of the approving authority
before the grant of renewal of approval.
(f)
The approved laboratory shall furnish reports of the results of tests or analysis in
Form 43.
(g)
In case any sample of Ayurvedic, Siddha or Unani drug is found t>n test to be not
of standard quality, the approved institution shall furnish to the approving authority and
the licensing authority of the State where the manufacturer and/or sender of the
Ayurvedic, Siddha or Unani drugs is located, with a copy of the test report on the
sample with the protocols of tests applied
(h)
The approved laboratory shall comply with the provisions of the Act and rules
made thereunder and with such further requirements, if any, as may be specified in the
rules subsequently made under Chapter IV - A of the Act of which the approving
authority has given the approved laboratory not less than four months' notice.
(i) The approved laboratory shall maintain an inspection book to enable the Inspector to
record his impression or defects noticed.
160 - E.- Inspection before grant of approval-Before an approval in Form £1 is
granted, the approving authority shall cause the laboratory at which the testing of
Ayurvedic, Siddha or Unani drup,s, as the case may be, is proposed to be carried out to
be inrpected jointly by the Inspectors appointed by the Central Government and a State
Govt'iTini-jn' Lin lot
section 13-0 who shall examine the premises and the equipment
19
intended to be used for testing of drugs
and
inquire
into
the
professional
qualifications of the expert staff who are or may be employed by the laboratory.
160 - F.- Report of inspection-The Inspectors of the Department of Indian Systems of
Medicine and Homoeopathy, of the Central Government referred to in rule 160 - E shall
forward the approving authority a detailed report of the results of the inspection within
two weeks of the date of such inspection.
160 - G.- Procedure of approving authority. - (1) If the approving authority after such
further enquiry, if any, as he may consider necessary, is satisfied that the requirements
of the rules made under the Act have been complied with and that the conditions of the
approval and the rules made under the Act have been observed, he shall grant approval
in Form 41 within
four weeks of the receipt of report of the Inspectors mentioned in
rule 160-F.
(2)
If the approving authority is not so satisfied, he shall reject the application and
shall inform the applicant of the reasons for such rejection and of the conditions which
must be satisfied before approval could be granted.
160 - H .- Further application after rejection-If within a period of six months from the
rejection of an application for approval, the applicant informs the approving authority
that the conditions laid down have been satisfied and deposits inspection fee of Rupees
two thousand, the approving authority may, if, after causing a further inspection to be
made and is satisfied that the conditions for grant of approval have been complied with,
grant the approval in Form 41.
160 - I.- Renewal-On an application being made for renewal, the approving authority
may after causing an inspection to be made and if satisfied that the conditions of the
approval and the rules made under the Act have been
complied with, shall issue a
certificate of renewal in Form 42
'V-?Cahom-H
20
THE GAZETTE OF TNDIA EXTRAORDTNARY
[PART II—SE< 3(I)]
160-J.-
Withdrawal
and suspension of approvals. - (1) The approving
authority may, after giving the approved laboratory an opportunity to show cause why
such an order should not be passed, by an order in writing stating the reasons therefor,
withdraw an approval granted under this Part or suspend it for such period as he thinks fit
either wholly or in respect of testing or analysing of some of the categories of Ayurvcdic,
Siddha or Unani drugs to which it relates, if in his opinion the approved laboratory had
failed to comply with any of the conditions of the approval or with any provision of the
Act or the rules made thereunder
(2)
Any approved laboratory institution whose approval has been suspended or
withdrawn may within three months of the date of the order, appeal to the State
Government which shall dispose of the appeal in consultation with a panel of competent
persons appointed by the Department of Indian Systems of Medicine and Homoeopathy,
Government of India in this behalf and notified in the Official Gazette
b)
in Schedule A, after Form 39, the following Forms shall be inserted, namely:-
FORM 40
(See rule 160-A)
Application for grant or renewal of approval for carrying out tests on Ayurvedic,
Siddha or Unani drugs or raw materials used in the manufacture thereof on behalf of
licensees for manufacture for sale of Ayurvedic, Siddha or Unani drugs
(1)
*1/We
of
hereby apply for the
grant/renewal of approval for carrying out tests of identity, punty, quality and strength
on the following categories of Ayurvedic, Siddha or Unani drugs or raw materials used
in the manufacture thereof on behalf of licenses for manufacture for sale of Ayurvedic,
Siddha or Unani drugs
(2)
*Categories of Ayurvedic, Siddha or Unani drugs other than those
specified in the first schedule to this Act for which testing will be carried out:
A.YURVEDA AND SIDDHA
1. Asava and Arista
2. Arka- Tinir
3. Avaleha and Paka - Ilakam
4. Kvatha Curna- Kutinir Curanam
5. Guggulu
6. Ghrta - Ney
7. Chuma - Curanam
8. Taila-Tailam
9. D ravaka - Ti ravakam
10. Lavana- Uppu
11. Ksara - Saram
12. Lepa- Pacai
13, Vati, Gutika - Kuhkai
14. Vartti -
15. Nctrabindu
16. An)ana - Kanmai
17. Sattva - Sattu
18. Kupipakva Rasayana- Kuppi Ccnturam
19. Parpati
20. Pisti
21. Bhasma - Parpam
22. Mandura - Atai Kutinir
23. Rasayoga- Ccnturam
24. Lauha
25, Ghana Sattva
26. Kvath Piavahi - Kutinir
27. Ganak (Syrup)- Manappaku
28. Tablet - Mattirai
29. Capsule
30. Ointment - Kalimapu
31. Phalvarti
32. Dhoomravarti/Doopan
33. Kshar Sutra/Kshar Varti
34. Single drugs-
la) Plant based
(b) Mineral based drugs
(c) Metal based drugs
(d) Animal based drugs
(c) S\nthetic drugs.
(f) Any other A^urvcdic Siddha, Unani formulation
35 Any other form of Patent & Proprietary
&
•Ayurvedic, Siddha, Unani Drug
UNANI
Nabeez
Araq
Majoon , Itrifal Guland, Halwa, Lashookh,
Luboob, Jawarish, Dawa,Khamccra, Laooq,
Safoof Johshanda
Safoof
Roughan
Namak
Khaar
Zimad
Habb
Shivaf
Qutoor
Kohal, Kajal,Surma
Satt
Kushta
Joslianda
Sharbat
Qurs
Marham
Humool
Bhakhoor
Nabati
Maadani
Ajsad
Haiwani
Jauhar
(Sublimation)
Natool
(Nasal drop)
22
GA
A.
A
At
[PART II—SEC I
(3)
Names, qualifications and experience of experts employed for testing and
the person-in-charge of testing.
(4)
List of testing equipment provided.
(5)
*I/We enclose a plan of the testing premises showing the location and area
of the different sections thereof.
(6)
An inspection fee of
rupees
has been credited to
Government under the head of account
Dated
Signature
Full Address of the Applicant
*
Delete whichever is not applicable.
FORM 41
(See rule 160-B)
Approval for carrying out tests or analysis on Ayurvedic, Siddha or Unani drugs
or raw materials used in the manufacture thereof on behalf of licensees for manufacture
for sale of Ayurvedic Siddha or Unani drugs.
Number of approval and date of issue:
(1)
Approval is hereby granted to
for
carrying out tests for identity, purity, quality and strength on the following categories of
Ayurvedic, Siddha or Unani drugs and the raw materials used in the manufacture thereof
on the premises situated at
Categories of Ayurvedic, Siddha or Unani, drugs
(2)
Names of .experts. employed
for testing and the person-in-charge of testing
(experts) and
(person in charge)
(3)
The approval shall be in force from
to
(4)
The approval is subject to the conditions stated below and such other conditions
as may be specified in the rules for the time being in force under the Act.
Signature
Daie^
Designation
PIace
Seal of State Licensing Authority
Conditions of Approval
(1)
This approval and any certificate of renewal in Form 42 shall be displayed
in the approved premises and shall be produced at the request of the
Inspectors appointed under the Act
(2)
If the applicant wishes to undertake during the currency of the approval
the testing of any other category of Ayurvedic, Siddha or Unani drugs it
should apply to the approving authority for necessary endorsement as
provided in Rule 160 A
This approval will be deemed to extend to the
items so endorsed
(3)
Any change in the experts or in the person-in-charge of the testing shall be
forthwith reported to the approving authority
(4)
The applicant shall inform the approving authority in writing in the
event of any change of the constitution of the laboratory operating under
this Form Where any change in the constitution of the laboratory takes
place, the current approval shall be deemed to be valid for a maximum
period of three months from the date on which the change takes place
unless in the meantime, a fresh approval
has been taken
from the
approving authority in the name of the laboratory with the changed
constitution
FORM 42
(See rule 160 -1)
Certificate of renewal for carrying out tests or analysis on Ayurvedic, Siddha or
Unani, drugs or raw materials used in the manufacture thereof on behalf of licensees for
manufacture for sale of Ayurvedic, Siddha or Unani, drugs
(1)
Certified that approval number
granted on
the
day of
2000 for carrying out tests of identity, purity, quality
and strength on the following categories of Ayurvedic, Siddha or Unani, drugs and the
raw materials used in
the manufacture thereof
at the premises situated at
has been renewed from
to
Categories of Ayurvedic, Siddha or Unani, drugs
(2)
Names
of
experts .,
and
the
person-in-charge
of
testing
(experts)and
(person
in charge)
Signature
Dale
Designation
Place
Seal of State Licen sing A ttfhoi ity
4
.
.
FORM 43
(See rule 160 - F)
Report of test or analysis by approved Laboratory
(1)
Name of
manufacturer from whom sample
received
together with his
manufacturing
licence number
under the Act or the rules made
thereunder.
(2)
Reference number and date of the letter from the manufacturer under which
the sample was forwarded.
(3)
Date of receipt of the sample.
(4)
Name of Ayurvedic, Siddha or Unani, drug or raw material purporting to be
contained in the sample.
(5)
Details of raw material or final product (in bulk finished pack)* as obtained
from the manufacturer:
a)
Original manufacturer's name in the case of raw materials and drugs repacked
b)
Batch number
c)
Batch size as represented by sample
d)
Date of manufacture, if any
e)
Date of expiry, if any
(6)
Results of test or analysis with protocols of test or analysis applied or as per
Ayurvedic, Siddha or Unani Pharmacopoeial standards.
(7)
Other specific tests for identity, purity quality and strength of Patent and
Proprietary drugs.
25
In the opinion of the undersigned, the sample referred to above is of standard
Equality/is not of standards quality as defined in the Act or the rules made thereunder
for the reasons given below
Date
(Signature of the Person-in-Charge of testing)
(F.NO
)
Place
Name & Designation
Note: Final product includes repacked material
"Delete whichever is not applicable.
INo K-11020/3/200()-DCC(ISM)]
L PRASAD. Jt Secy
Foot Note:- The Principal
Rules were published in the Official
Gazette vide
Notification
No.F.28-10/45-H(l) dated
21s1 December, 1945 and last
amendment vide GSR No. 6(E) dated 4 1.2001. The Drugs and Cosmetics
Rules, 1945 as amended up to 1.5.1979 is contained in the publication of
the Ministry of Health and Family Welfare (Department of Health)
containing the Drugs and Cosmetics Act, 1940 (PDGHS- 61)
Printed by the Manager, Govt of India Press, Ring Road. Ma\ apun. New Delhi-110064
and Published bv the Controller of Publications, Delhi-110054